NR1H4 and metabolic dysfunction-associated steatohepatitis: Experimental models in animals show that the pathogenesis of NASH is likely linked with a markedly altered composition of BA in the enterohepatic- rather than in the systemic circulation, with specific reduction of secondary BAs (mainly DCA), and scarce presence of FXR and TGR5 ligands in the portal blood.